What is the recommended treatment for Sydenham chorea in a 15‑kg child, including antichorea medication, anti‑inflammatory therapy, and secondary streptococcal prophylaxis?

Treatment of Sydenham Chorea in a 15-kg Child

All children with Sydenham chorea should receive immediate antibiotic treatment at first presentation, corticosteroid immunotherapy for moderate-to-severe disease, and long-term secondary antibiotic prophylaxis following international guidelines 1.

Immediate Antibiotic Treatment

Start antibiotics at diagnosis to eradicate Group A streptococcal infection, even if throat culture is negative (as SC typically presents weeks to months after the initial infection). The 2025 international consensus guidelines strongly recommend antibiotic treatment at first presentation 1.

For a 15-kg child, use:

• Benzathine penicillin G (preferred): Single intramuscular dose
• Alternative: Oral penicillin V or azithromycin if IM route not feasible 2

Anti-Inflammatory/Immunotherapy

The treatment approach depends on disease severity:

Moderate to Severe SC

Corticosteroids are the first-line immunotherapy 1. The evidence strongly supports this:

• A 2024 meta-analysis demonstrated that corticosteroid treatment ≥1 month was associated with significantly shorter chorea duration (median 1.2 months vs 2.8 months without corticosteroids, P=0.004) 3
• Corticosteroids reduced odds of relapsing disease course (OR 0.10, P<0.001) 3
• The 2025 consensus guidelines recommend corticosteroids for moderate-to-severe SC based on expert consensus 1

Dosing approach:

• Prednisone/prednisolone: typical dosing based on severity
• Duration: minimum 1 month, with gradual taper over 12 weeks total anti-inflammatory treatment 2

Inadequate Recovery After 2-4 Weeks

If functional recovery is inadequate (chorea or behavioral symptoms remain intrusive/disabling) after 2-4 weeks of corticosteroid treatment:

• Escalate to IVIG or plasma exchange 1
• This period can be shorter for severe SC 1

Mild SC

For mild cases, symptomatic treatment alone may be sufficient, though corticosteroids still reduce relapse risk 3.

Symptomatic Antichorea Medication

While not addressing the underlying autoimmune process, symptomatic medications can provide relief:

First-line symptomatic agents:

• Valproic acid/sodium valproate: Associated with monophasic disease course (OR 0.33 for relapse, P=0.004) 3
  • Continue for 2-3 weeks after clinical improvement 2
  • For a 15-kg child: weight-based dosing per standard protocols

Second-line options (for more severe chorea):

• Carbamazepine 4
• Dopamine receptor blocking agents (use cautiously due to side effect profile) 4

Important caveat: The 2025 guidelines emphasize that symptomatic medications alone do not prevent relapse as effectively as immunotherapy 1, 3.

Secondary Prophylaxis

Long-term secondary antibiotic prophylaxis is mandatory to prevent recurrent streptococcal infections, ARF recurrence, and progression to rheumatic heart disease 1.

For a 15-kg child:

• Benzathine penicillin G (preferred): Intramuscular injection every 3-4 weeks
• Measures to reduce pain/distress with IM injections improve adherence 1
• Alternative: Oral penicillin V daily (if IM not tolerated)

Duration of prophylaxis:

• Follow international or local ARF guidelines 1
• Typically continues for years (minimum 5 years or until age 21, whichever is longer; longer if carditis present) 2

Treatment Algorithm Summary

1. At diagnosis:

   • Start antibiotics immediately (benzathine penicillin G IM preferred)
   • Assess severity using modified Rankin Scale 1
   • Screen for carditis (present in up to 81% of SC cases) 1

2. For moderate-to-severe SC:

   • Initiate corticosteroids (≥1 month duration)
   • Consider adding valproic acid for symptomatic control
   • Total anti-inflammatory treatment: 12 weeks 2

3. If inadequate response at 2-4 weeks:

   • Escalate to IVIG or plasma exchange 1

4. For mild SC:

   • Consider valproic acid alone initially
   • Add corticosteroids if symptoms progress or to reduce relapse risk

5. All patients:

   • Begin long-term secondary prophylaxis with benzathine penicillin G IM every 3-4 weeks
   • Provide family education and school support 1
   • Monitor for relapse (recurrence after ≥1 month stability) 1

Critical Pitfalls to Avoid

• Don't delay antibiotics waiting for positive throat culture—SC presents late after infection 1
• Don't use corticosteroids alone without antibiotics—both are needed 1
• Don't stop secondary prophylaxis prematurely—this is lifelong or near-lifelong prevention 1, 2
• Don't miss subclinical carditis—obtain echocardiography even without cardiac symptoms 1
• Don't use short corticosteroid courses—minimum 1 month is needed for benefit 3

The 2025 international consensus represents the most comprehensive and recent guidance, synthesizing expert opinion with the 2024 meta-analysis showing clear benefits of immunotherapy, particularly corticosteroids ≥1 month duration, for both symptom resolution and preventing relapsing disease 1, 3.